Explore drug properties, targets, and indications with answers grounded in DrugCentral.
Powered by DrugCentral + retrieval-augmented AIAsk in your own words. Each question is answered independently.
Select a question to fill the editor, then ask it or make it your own.
Your answer will appear here. Open linked drug cards in a new tab to explore the source details.
Ask DrugCentral helps you explore drug properties, biological targets, and indications using natural language. Sample questions offer starting points, and linked drug cards let you check the underlying records.
Each request is independent; previous questions are not sent as conversation history. You can edit a sample before submitting, retry a failed request, or switch back to normal search. Drug links open in a new tab so your question and answer stay available.
Answers may contain mistakes or omit information. Verify details against DrugCentral records and original sources.
AI can make mistakes. Verify answers against the original sources before relying on them.
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 4217 | 127-08-2 |
| Molecule | Description |
|---|---|
|
Synonyms:
|
A potassium salt used to replenish ELECTROLYTES, for restoration of WATER-ELECTROLYTE BALANCE, as well as a urinary and systemic alkalizer, which can be administered orally or by intravenous infusion. Formerly, it was used in DIURETICS and EXPECTORANTS.
|
None
None
None
| Date | Agency | Company | Orphan |
|---|---|---|---|
| Sept. 24, 1971 | FDA | B BRAUN |
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Gingival disorder | 26.02 | 21.87 | 7 | 1430 | 3984 | 90623026 |
None
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Gingival disorder | 31.32 | 22.57 | 8 | 1571 | 4145 | 110583575 |
None
| Source | Code | Description |
|---|---|---|
| ATC | B05XA17 | BLOOD AND BLOOD FORMING ORGANS BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS I.V. SOLUTION ADDITIVES Electrolyte solutions |
| CHEBI has role | CHEBI:64049 | food acidity regulator |
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Hypokalemia | indication | 43339004 | |
| Hypokalemia Prevention | indication |
None
None
None
None
None
None
| ID | Source |
|---|---|
| 4017517 | VUID |
| N0000145902 | NUI |
| D01154 | KEGG_DRUG |
| 4017517 | VANDF |
| C0137984 | UMLSCUI |
| CHEBI:32029 | CHEBI |
| CHEMBL1201058 | ChEMBL_ID |
| D019347 | MESH_DESCRIPTOR_UI |
| DB14498 | DRUGBANK_ID |
| M911911U02 | UNII |
| 517044 | PUBCHEM_CID |
| 54987 | RXNORM |
| 1780 | MMSL |
| 5322 | MMSL |
| d03777 | MMSL |
| 000764 | NDDF |
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| Potassium Acetate | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0409-3294 | INJECTION, SOLUTION, CONCENTRATE | 196.30 mg | INTRAVENOUS | NDA | 12 sections |
| Potassium Acetate | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0409-3294 | INJECTION, SOLUTION, CONCENTRATE | 196.30 mg | INTRAVENOUS | NDA | 12 sections |
| Potassium Acetate | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0409-8183 | INJECTION, SOLUTION, CONCENTRATE | 3.93 g | INTRAVENOUS | NDA | 15 sections |
| Potassium Acetate | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0409-8183 | INJECTION, SOLUTION, CONCENTRATE | 3.93 g | INTRAVENOUS | NDA | 15 sections |
| NORMOSOL-M AND DEXTROSE | HUMAN PRESCRIPTION DRUG LABEL | 4 | 0990-7965 | INJECTION, SOLUTION | 128 mg | INTRAVENOUS | NDA | 14 sections |
| NORMOSOL-M AND DEXTROSE | HUMAN PRESCRIPTION DRUG LABEL | 4 | 0990-7965 | INJECTION, SOLUTION | 128 mg | INTRAVENOUS | NDA | 14 sections |
| Potassium Acetate | HUMAN PRESCRIPTION DRUG LABEL | 1 | 51754-2001 | INJECTION, SOLUTION, CONCENTRATE | 3.93 g | INTRAVENOUS | ANDA | 12 sections |
| Potassium Acetate | HUMAN PRESCRIPTION DRUG LABEL | 1 | 51754-2004 | INJECTION | 200 meq | INTRAVENOUS | ANDA | 12 sections |
| Potassium Acetate | HUMAN PRESCRIPTION DRUG LABEL | 1 | 51754-2005 | INJECTION | 100 meq | INTRAVENOUS | ANDA | 12 sections |
| Potassium Acetate | HUMAN PRESCRIPTION DRUG LABEL | 1 | 65219-510 | INJECTION, SOLUTION, CONCENTRATE | 3.93 g | INTRAVENOUS | ANDA | 15 sections |
| Potassium Acetate | HUMAN PRESCRIPTION DRUG LABEL | 1 | 65219-512 | INJECTION, SOLUTION, CONCENTRATE | 196 mg | INTRAVENOUS | ANDA | 15 sections |